GR3036211T3 - Taxane class derivative based pharmaceutical compositions - Google Patents

Taxane class derivative based pharmaceutical compositions

Info

Publication number
GR3036211T3
GR3036211T3 GR20010400339T GR20010400339T GR3036211T3 GR 3036211 T3 GR3036211 T3 GR 3036211T3 GR 20010400339 T GR20010400339 T GR 20010400339T GR 20010400339 T GR20010400339 T GR 20010400339T GR 3036211 T3 GR3036211 T3 GR 3036211T3
Authority
GR
Greece
Prior art keywords
pharmaceutical compositions
based pharmaceutical
derivative based
taxane class
class derivative
Prior art date
Application number
GR20010400339T
Other languages
English (en)
Inventor
Manfred Durr
Joerg-Christian Hager
Armin Wendel
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of GR3036211T3 publication Critical patent/GR3036211T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
GR20010400339T 1994-04-25 2001-07-12 Taxane class derivative based pharmaceutical compositions GR3036211T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9404951A FR2718963B1 (fr) 1994-04-25 1994-04-25 Nouvelle composition pharmaceutique à base de taxoïdes.
PCT/FR1995/000532 WO1995028923A1 (fr) 1994-04-25 1995-04-24 Compositions pharmaceutiques a base de derives de la classe des taxanes

Publications (1)

Publication Number Publication Date
GR3036211T3 true GR3036211T3 (en) 2001-10-31

Family

ID=9462475

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400339T GR3036211T3 (en) 1994-04-25 2001-07-12 Taxane class derivative based pharmaceutical compositions

Country Status (26)

Country Link
US (1) US5670536A (el)
EP (1) EP0758231B1 (el)
JP (1) JP3950993B2 (el)
KR (1) KR100401119B1 (el)
CN (1) CN1283243C (el)
AT (1) ATE202931T1 (el)
AU (1) AU691283B2 (el)
BR (1) BR9507846A (el)
CZ (1) CZ285720B6 (el)
DE (1) DE69521693T2 (el)
DK (1) DK0758231T3 (el)
ES (1) ES2160163T3 (el)
FI (1) FI118204B (el)
FR (1) FR2718963B1 (el)
GE (1) GEP20002069B (el)
GR (1) GR3036211T3 (el)
HU (1) HU225971B1 (el)
NO (1) NO314745B1 (el)
NZ (1) NZ285122A (el)
PL (1) PL179623B1 (el)
PT (1) PT758231E (el)
RU (1) RU2157200C2 (el)
SK (1) SK283255B6 (el)
TW (1) TW416849B (el)
WO (1) WO1995028923A1 (el)
ZA (1) ZA953358B (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698871B1 (fr) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US6096331A (en) * 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US6395770B1 (en) 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6245805B1 (en) 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
BRPI9810945B8 (pt) * 1997-06-27 2021-05-25 Abraxis Bioscience Inc formulações de agentes farmacológicos, métodos para sua preparação e métodos para uso das mesmas
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
SK287775B6 (sk) * 1998-02-05 2011-09-05 Novartis Ag Farmaceutická formulácia obsahujúca epothilon, infúzny roztok a použitie farmaceutickej formulácie
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
RU2213746C1 (ru) * 2002-02-15 2003-10-10 Научно-исследовательский институт физико-химической медицины Компонент, обеспечивающий поверхностно-активные свойства композиций - аналогов препаратов для заместительной сурфактантной терапии легочных заболеваний
DE10255285A1 (de) * 2002-11-26 2004-06-03 Mcs Micro Carrier Systems Gmbh Selbst formende Phospholipid-Gele
US20050152979A1 (en) * 2003-09-05 2005-07-14 Cell Therapeutics, Inc. Hydrophobic drug compositions containing reconstitution enhancer
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US7446126B2 (en) * 2004-10-08 2008-11-04 Indena S.P.A. Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
JP2010524919A (ja) * 2007-04-23 2010-07-22 サン、ファーマスーティカル、インダストリーズ、リミテッド 医薬組成物
EP1987813A1 (en) * 2007-05-04 2008-11-05 Pharmatex Italia Srl Injectable pharmaceutical formulation of taxoids in stable liposomes
RU2370261C2 (ru) * 2007-08-03 2009-10-20 Закрытое Акционерное Общество "Биокад" Стабильная эмульсия для парентерального введения плохо растворимых в воде соединений, обладающих противоопухолевой активностью, и способ ее получения
EP2205215A2 (en) * 2007-10-01 2010-07-14 Intas Pharmaceuticals Limited Docetaxel injectable composition, being absolutely free of ethanol
CN101971189A (zh) * 2007-11-07 2011-02-09 爱墨菲特有限公司 压痕泡沫数字扫描仪
RU2370258C2 (ru) * 2007-11-16 2009-10-20 Закрытое Акционерное Общество "Биокад" Фармацевтическая композиция для парентеральной доставки в форме лиофилизата и способ ее получения
ES2344674B1 (es) * 2008-08-07 2011-06-29 Gp Pharm, S.A. Composicion farmaceutica inyectable de taxanos.
US8541360B2 (en) * 2008-11-19 2013-09-24 Ben Venue Laboratories, Inc. Parenteral formulations comprising sugar-based esters and ethers
WO2012156999A1 (en) * 2011-05-19 2012-11-22 Manu Chaudhary Ready to use docetaxel formulation
ES2687705T3 (es) 2012-07-19 2018-10-26 Fujifilm Corporation Composición líquida que contiene un principio activo a base de taxano, proceso de producción de la misma y preparación medicinal líquida
EA022182B1 (ru) * 2012-12-24 2015-11-30 Общество С Ограниченной Ответственностью "Технология Лекарств" Способ получения липосомальной формы доцетаксела

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4534899A (en) * 1981-07-20 1985-08-13 Lipid Specialties, Inc. Synthetic phospholipid compounds
US4507217A (en) * 1983-03-07 1985-03-26 Lipid Specialties, Inc. Magnetic compositions and magnetic memory devices prepared therefrom
US5411947A (en) * 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
EP0706373B1 (en) * 1992-03-23 2000-07-19 Georgetown University Liposome encapsulated taxol and a method of using the same
AU6833994A (en) * 1993-05-17 1994-12-12 Liposome Company, Inc., The Incorporation of taxol into liposomes and gels
WO1994026253A1 (en) * 1993-05-19 1994-11-24 The Liposome Company, Inc. Liposome having a multicomponent bilayer which contains a bioactive agent as an integral component of the bilayer
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation

Also Published As

Publication number Publication date
GEP20002069B (en) 2000-05-10
CZ309396A3 (en) 1997-01-15
SK283255B6 (sk) 2003-04-01
NO964433D0 (no) 1996-10-18
CN1283243C (zh) 2006-11-08
FI118204B (fi) 2007-08-31
DE69521693D1 (de) 2001-08-16
FR2718963B1 (fr) 1996-05-24
DK0758231T3 (da) 2001-09-24
AU2412695A (en) 1995-11-16
ATE202931T1 (de) 2001-07-15
PT758231E (pt) 2001-11-30
PL179623B1 (pl) 2000-10-31
SK135696A3 (en) 1997-05-07
FR2718963A1 (fr) 1995-10-27
HU225971B1 (en) 2008-01-28
FI964285L (fi) 1996-10-24
BR9507846A (pt) 1997-09-16
ES2160163T3 (es) 2001-11-01
ZA953358B (en) 1996-01-17
KR100401119B1 (ko) 2004-03-19
JPH09512261A (ja) 1997-12-09
EP0758231B1 (fr) 2001-07-11
NO314745B1 (no) 2003-05-19
KR970702033A (ko) 1997-05-13
NZ285122A (en) 1998-06-26
JP3950993B2 (ja) 2007-08-01
RU2157200C2 (ru) 2000-10-10
FI964285A0 (fi) 1996-10-24
EP0758231A1 (fr) 1997-02-19
NO964433L (no) 1996-10-18
AU691283B2 (en) 1998-05-14
CN1146722A (zh) 1997-04-02
HUT75513A (en) 1997-05-28
TW416849B (en) 2001-01-01
DE69521693T2 (de) 2002-05-02
PL316942A1 (en) 1997-02-17
CZ285720B6 (cs) 1999-10-13
US5670536A (en) 1997-09-23
HU9602942D0 (en) 1996-12-30
WO1995028923A1 (fr) 1995-11-02

Similar Documents

Publication Publication Date Title
GR3036211T3 (en) Taxane class derivative based pharmaceutical compositions
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
HUP0301405A2 (hu) Fokozott oldékonyságú gyógyhatású komponenseket tartalmazó készítmények
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
PT977562E (pt) Metodos e composicoes para administracao de taxanos
MX9306924A (es) Composiciones antitumorales que contienen derivados de taxano.
DE60133555D1 (de) Verbindungen und gemische zur verabreichung eines aktiven agens
PT977564E (pt) Forscolina para promocao da massa corporal magra
ATE148630T1 (de) Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen
MXPA02012611A (es) Composicion anestesica, acuosa, clara.
AR021370A1 (es) Composiciones farmaceuticas inyectables estabilizadas que contienen agentes anti-neoplasicos taxoides
KR970705553A (ko) 디히드로벤조푸란, 및 항염증 약물로서 유용한 관련 화합물(dihydrobenzofuran and related compounds useful as anti-inflammatory agents)
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
DK0917460T3 (da) Cyclosporin-formulering
ES2105923B1 (es) Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv).
ATE417619T1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung
ID23900A (id) Turunan-turunan dolastatin-15 dalam kombinasi dengan taksana
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
MX9604984A (es) Composiciones farmaceuticas a base de derivados de la clase de los taxanos.
ATE208627T1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen
ES2179667T3 (es) Nuevas formulaciones inyectables que contienen ramoplanina.
CA2188599A1 (fr) Compositions pharmaceutiques a base de derives de la classe des taxanes